Kristen Rice, MD
Dermatology · Tulsa, OKNPI 1871826115
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.4% of the total across 444 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations.
Across 444 payments — averaging $20.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- E.r. Squibb & Sons, L.L.C.$765
- Novartis$719
- Johnson & Johnson$694
- Amgen$651
- Lilly USA, LLC$531
- plus $4K from 25 others
Across 35 payments — averaging $1360.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Galderma Research & Development, LLC$45K
- Dermavant Sciences, Inc.$3K
What the payments were for
- Speaking & faculty fees$5006%
- Food & beverage$8,48193%
- Education$951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 70 | $2,138 |
| E.r. Squibb & Sons, L.L.C. | 36 | $765 |
| Novartis | 38 | $719 |
| Johnson & Johnson | 36 | $694 |
| Amgen | 31 | $651 |
| Lilly USA, LLC | 21 | $531 |
| Arcutis Biotherapeutics, Inc. | 39 | $399 |
| UCB, Inc. | 19 | $398 |
| Sun Pharmaceutical Industries Inc. | 19 | $356 |
| Pfizer | 18 | $314 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $264 |
| Dermavant Sciences, Inc. | 14 | $216 |
| LEO Pharma Inc. | 11 | $214 |
| Galderma Laboratories, L.p. | 13 | $213 |
| Regeneron Healthcare Solutions, Inc. | 10 | $179 |
| VYNE Pharmaceuticals Inc. | 6 | $147 |
| Almirall LLC | 7 | $145 |
| Sanofi | 6 | $138 |
| Bristol Myers Squibb | 12 | $130 |
| Mayne Pharma Commercial LLC | 10 | $119 |
| Conmed Corporation | 1 | $73 |
| Boehringer Ingelheim | 4 | $58 |
| Dermira, Inc. | 2 | $39 |
| Prugen, Inc. Pharmaceuticals | 3 | $36 |
| Sandoz | 2 | $34 |
| DUSA Pharmaceuticals, Inc. | 1 | $23 |
| Organogenesis Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $17 |
| Botanix SB Inc | 1 | $15 |
| Organon | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$500
- Sotyktu$125
- DUOBRII$124
How this compares
$9,076 in reported general payments places this provider in the 75th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 112 | $4,569 |
| Ketoconazole | 268 | $4,100 |
| Doxycycline Hyclate | 108 | $3,349 |
| Fluocinonide | 76 | $2,291 |
| Triamcinolone Acetonide | 95 | $1,232 |
| Metronidazole | 25 | $1,052 |
| Mycophenolate Mofetil | 21 | $958 |
| Hydrocortisone | 116 | $950 |
| ValacyclovirValacyclovir Hcl | 41 | $925 |
| Minoxidil | 124 | $925 |
| Fluconazole | 55 | $659 |
| Clindamycin Phosphate | 16 | $607 |
| Finasteride | 38 | $446 |
| Mupirocin | 55 | $346 |
| Terbinafine Hcl | 12 | $235 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tulsa
- George MonksTulsa$530K
- Jeff AlexanderTulsa$41K
- Johnathan LedetTulsa$37K
- John AshleyTulsa$24K
- Alison FischerTulsa$18K
- Mark LehmanTulsa$17K
- Kelli LovelaceTulsa$14K
- Bernard RobinowitzTulsa$14K
- Christina KendrickTulsa$13K
- Ashwini VaidyaTulsa$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.